Deborah Levine: Nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P2225 - ESOC25-874 USE OF ANTIDEPRESSANTS IN YOUNG STROKE PATIENTS: INSIGHTS FROM A MULTICENTER STUDY Jenna Broman 1 , Daniela Pinter 2 , Simon Fandler-Hfler, Bettina von Sarnowski 3 , Mohamed Elmegiri 4 , Thomas Gattringer 5,6 , Robert Malinowski 3 , Juha Martola 4 , Stefan Ropele, Ulf Schminke 3 , Turgut Tatlisumak 1,7 , Christian Enzinger, Karoliina Aarnio 1 , Jukka Putaala 1 1 Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 2 Department of Neurology, Research Unit for Neuronal Plasticity and Repair, Medical University of Graz, Graz, Austria, 3 Department of Neurology, University Medicine Greifswald, Greifswald, Germany, 4 Department of Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 5 Department of Neurology, Medical University of Graz, Graz, Austria, 6 Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz, Graz, Austria, 7 Department of Clinical Neuroscience, Institute of Neurosciences and Physiology, Sahlgrenska Academy at University of Gothenburg & Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden Background and Aims: Depression after stroke is common and occurs in approximately one-third of patients, potentially affecting their quality of life and worsening the outcome
Barends M, Verschuren L, Morava E, Nesbitt V, Turnbull D, McFarland R (2016) Causes of death in adults with mitochondrial disease
For optimal absorption, it is generally recommended to take glutathione on an empty stomach, either in the morning or before bed
In doing so, it may stave off age-related diseases associated with telomere shortening,36 strengthen the immune system,37 and improve sleep health.38 Delta sleep-inducing peptide (DSIP): As its name suggests, DSIP helps with sleep
Endosomal-lysosomal dysfunctions in Alzheimers disease: pathogenesis and therapeutic interventions
